Comment on "MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC".

{"title":"Comment on \"MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC\".","authors":"Xinglin Wang, Xiuxiu Zhang","doi":"10.1016/j.jtho.2024.08.012","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 12","pages":"e87-e88"},"PeriodicalIF":21.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtho.2024.08.012","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}